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The twin-arginine protein transport (Tat) machinery mediates the transloca-
tion of folded proteins across the cytoplasmic membrane of prokaryotes and
the thylakoid membrane of plant chloroplasts. The Escherichia coli Tat system
comprises TatC and two additional sequence-related proteins, TatA and
TatB. The active translocase is assembled on demand, with substrate-binding
at a TatABC receptor complex triggering recruitment and assembly of
multiple additional copies of TatA; however, the molecular interactions
mediating translocase assembly are poorly understood. A ‘polar cluster’
site on TatC transmembrane (TM) helix 5 was previously identified as bind-
ing to TatB. Here, we use disulfide cross-linking and molecular modelling to
identify a new binding site on TatC TM helix 6, adjacent to the polar cluster
site. We demonstrate that TatA and TatB each have the capacity to bind at
both TatC sites, however in vivo this is regulated according to the activation
state of the complex. In the resting-state system, TatB binds the polar cluster
site, with TatA occupying the TM helix 6 site. However when the system is
activated by overproduction of a substrate, TatA and TatB switch binding
sites. We propose that this substrate-triggered positional exchange is a key
step in the assembly of an active Tat translocase.
1. Introduction
The twin-arginine protein transport (Tat) pathway operates in parallel with the
general secretory (Sec) pathway to export proteins across the cytoplasmic
membrane of bacteria and archaea, and the thylakoid membrane of plant chlor-
oplasts. Tat substrates have N-terminal signal peptides containing a conserved
twin-arginine motif and are transported across the membrane in a folded state
driven by the protonmotive force [1–3].
The Tat machinery comprises membrane proteins from the TatA and TatC
families. TatA family proteins are monotopic with an N-out transmembrane
(TM) helix at their N-terminus, followed by a cytoplasmically located amphi-
pathic helix [4,5]. Most Gram-negative bacteria, and plant thylakoids, have
two functionally distinguishable TatA paralogues (TatA and TatB in bacteria)
that have distinct roles in Tat transport (e.g. [6,7]). TatC is the core component
of the Tat system, and forms a scaffold for the dynamic assembly of Tat com-
plexes during protein translocation [8,9]. Tat transport is initiated by binding
of the signal peptide of a Tat substrate to the Tat(A)BC receptor complex.
This complex, which contains several copies of TatB and TatC, is multivalent
and appears to function as an obligate oligomer [10–13]. Although the
Tat(A)BC complex is stable and can interact with substrates in the absence of
TatA [13,14], it is likely that in vivo some TatA constitutively associates with
this complex, most likely in an equimolar ratio with TatB and TatC [10,15–17].
& 2017 The Authors. Published by the Royal Society under the terms of the Creative Commons Attribution
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The signal peptide twin-arginine motif is recognized by
the cytoplasmic surface of TatC [9,18]. The signal peptide
can also bind more deeply within the receptor complex,
contacting residues in the TM helix of TatB and towards the
periplasmic end of TatC TM helix 5 (TM5) [18–20]. Following
substrate binding, additional TatA protomers are recruited to
the receptor complex dependent on the protonmotive force
[16,19,21–25]. According to current models, the assembled
TatA oligomer facilitates substrate translocation across the
membrane either through formation of a size-variable chan-
nel or by promoting localized membrane weakening and
transient bilayer disruption (see [1,2] for recent reviews).
Although high-resolution structural information is avail-
able for TatA, TatB and TatC [8,9,26–29], to date Tat
complexes have only been visualized at low resolution
[13,30,31]. Site-specific cross-linking has been used to map
interaction interfaces between Tat components, giving results
consistent with a potential binding site for TatB being located
along one face of TatC TM5 [9,20,32]. One such study
additionally suggested that TatB might control access of
TatA to TatC [20], and a cross-linking study of the pea Tat
system suggested that cross-links between Tha4 (TatA) and
cpTatC TM5 were enhanced by addition of a substrate
[16]. Recently, coevolution analysis independently predicted
the location a TatA/TatB binding site along TM5 of TatC,
pointing to a polar cluster of amino acids in E. coli TatC
(M205, T208 and Q215) forming likely contacts with a
polar side chain in TatA and TatB [15]. TatB was demon-
strated to occupy this site in the resting translocase, and
further experiments with alanine-substituted polar cluster
variants suggested that TatA and TatB might differentially
occupy the same TatC TM5 site at different stages of Tat
transport [15].
In this work, we have undertaken an in vivo disulfide
cross-linking study to explore the interaction of TatC with
TatA and TatB in the absence of a bound substrate and
when a substrate is likely to be bound. Our studies identify
two binding sites for each protein. The first of these, at TatC
TM5, is occupied by TatB under resting conditions,
consistent with the studies described above. We identified
an additional binding site located at TatC TM6 which we
show is occupied by TatA in the resting state. Combining
the cross-linking data with evolutionary coupling and mol-
ecular modelling allowed us to predict the precise position
of the entire TatA TM helix, which was shown by molecular
dynamics simulation to be stable in this site, and was con-
firmed by further targeted cross-linking experiments. We
go on to show that in the presence of over-expressed Tat
substrate TatA and TatB move positions to occupy each
other’s binding sites, and we therefore propose that signal
peptide-triggered position switching of TatA and TatB is
a critical step in driving the assembly of an active Tat
translocase.
2. Results
2.1. The TatB TM helix is positioned close to TM5 of TatC
at the polar cluster site under resting conditions
Prior disulfide cross-linking studies between E. coli TatB and
TatC used isolated membrane fractions harbouring elevated
copies of Tat components. Under these conditions an initial
contact site between TatBL9C and TatCM205C was identified
[32], which was subsequently extended to reveal further con-
tacts between Cys residues introduced into the TM helix of
TatB and into TM5 of TatC [9]. To explore whether the
same contact sites were detectable in vivo, we developed a
protocol for disulfide cross-linking in intact cells using
the TatBL9C –TatCM205C cross-link. In these experiments, the
Cys-substituted variants of TatB and TatC were produced
from the low copy number plasmid p101C*BC, which
expresses tatBC at approximately chromosomal level [21], in
a strain lacking chromosomal tatBC. An initial titration with
the oxidant copper phenanthroline (CuP) revealed that a
TatBC cross-link was detectable when CuP was used at 1.2
and 1.8 mM (figure 1a). We also noted that TatB and TatC
homodimers were formed through the introduced Cys resi-
dues after incubation with CuP, as reported previously
[9,32]. Next, using 1.8 mM CuP, we undertook a time
course from 1 to 15 min and examined the formation of the
TatBC heterodimer and the survival of cells during this
period. Figure 1b shows a TatBC heterodimer was detected
at all time points, including the earliest time point tested;
however, incubation times with CuP in excess of 1 min saw
a significant reduction in the recovery of cells (figure 1c).
We therefore chose to use a 1 min incubation with 1.8 mM
CuP for all subsequent cross-linking analysis.
Next we introduced Cys residues into a scanning region
of TatC from residue 205 in TM5, through the periplasmic
P3 loop as far as residue 216 in TM6 (figure 2a). Figure S1
in the electronic supplementary material shows that when
each of these TatC Cys substitutions was co-produced with
TatBL9C, cells were able to grow in the presence of 2% SDS.
This indicates successful export of Tat substrates AmiA and
AmiC [33] and therefore that the Cys substitutions did not
abolish Tat transport activity. Following incubation of cells
producing each of these variants with CuP, a TatBC heterodi-
mer was primarily detected between TatBL9C and TatCM205C
(figure 2b,c). A faint TatBC heterodimer band was also seen
between TatBL9C and TatCL206C, and a fainter one between
TatBL9C and TatCF213C that was only detected with the anti-
TatB antibody (indicated with asterisks on figure 2b). It
should be noted that the TatB antiserum used in this scanning
experiment is a polyclonal anti-peptide antibody that primar-
ily recognizes the C-terminal 15 amino acids of TatB and
detects the TatB homodimer as a doublet band (electronic
supplementary material, figure S2) for reasons that are
unclear.
Alcock et al. [15] identified a binding site for TatA/TatB
close to the polar cluster of residues M205, T208 and Q215
in TatC. Molecular dynamics simulations (MDS) indicated
that TatB E8 may hydrogen bond with both T208 and Q215
when bound at this site. We were unable to explore this
directly by disulfide cross-linking because a Cys substitution
at TatBE8 abolished Tat activity when expressed from plasmid
p101C*BC (electronic supplementary material, figure S1a).
This is consistent with the loss of activity noted for a
TatBE8A substitution, which resulted in destabilization of
the TatB–TatC interaction [15]. However, molecular model-
ling indicates that when TatB interacts with TatC via the
polar cluster, L9 of TatB may be positioned within 6.6 A˚ of
TatCM205 (backbone distances; figure 2d ). We therefore con-
clude that the disulfide cross-link formed between TatBL9C
and TatCM205C arises from interaction of TatB at the TatC
polar cluster site. To confirm this we undertook disulfide
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cross-linking between TatBG16C and TatCV198C (figure 2d ),
which are one of the most highly covarying pairs of residues
at the polar cluster site [15]. Figure 2e shows that, as expected,
a cross-link is formed between these two cysteine residues
when cells were oxidized. These results give full support to
the binding mode of TatB described previously [15].
Experiments using a variant of TatC that is unable to bind
signal peptides (TatCF94A,E103A) led to the conclusion that the
interaction of TatB at the TatC polar cluster site occurred
when the Tat system was at rest [15]. Figure 2f shows that
in agreement with this, introduction of these same TatC
substitutions did not abolish the TatBL9C and TatCM205C
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Figure 1. Development of an in vivo disulfide cross-linking protocol. Cells of strain MC4100DBC (DtatBC) harbouring plasmid p101C*BC producing
TatBL9C alongside TatCM205C were incubated with either LB medium (control, C), or LB supplemented with 10 mM DTT (reduced; R) or (a) the
indicated concentrations of CuP for 15 min or (b) with 1.8 mM CuP for 1–15 min. The reaction was quenched by addition of 8 mM NEM/12 mM
EDTA, membranes were prepared and proteins were separated by SDS-PAGE (10% polyacrylamide). Cross-linked products were visualized by immunoblotting
using anti-TatBFL or anti-TatC antibodies, as indicated. (c) Aliquots of cells from the oxidized and control samples in (b) were spread on LB plates containing
chloramphenicol and the number of colonies enumerated following growth at 378C for 24 h. The y-axis shows the ratio of the number of colony forming
units (cfu) obtained after incubation with 1.8 mM CuP compared to the number after incubation in LB medium only; n ¼ 3 biological replicates, error bars
are +s.d.
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cross-link. Thus TatB occupies the polar cluster binding site
under resting conditions in vivo.
2.2. In the resting Tat system TatA interacts at a distinct
site on TatC close to TM6
Next we used a similar approach to determine whether we
could detect in vivo interactions between TatA and TatC.
Initially, Cys-substituted variants of TatA and TatC were
produced alongside TatB under control of the lac promoter
from plasmid pQE60 and expressed in strain DADE-P [34]
that lacks chromosomally encoded tatABC/tatE and which
harbours the pcnB1 allele to limit plasmid copy number to
1–2 per cell [35]. Cys substitutions were introduced at L9,
L10 and I11 of TatA and these were tested with the same
Cys-scanning region from residues 205–216 of TatC.
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Figure 2. TatBL9C interacts with TatCM205C in vivo. (a) Homology model of E. coli TatC showing positions of the residues used for disulfide cross-linking analysis in
yellow. The side-chains of M205 and F213 are indicated. (b,c) Western blot analysis (separated on 10% polyacrylamide gels) of membranes from E. coli strain
MC4100DBC producing TatBL9C alongside the indicated Cys substitutions in TatC (from plasmid p101C*BC) following exposure of whole cells to 1.8 mM CuP (oxidiz-
ing) or 10 mM DTT (reducing) for 1 min. Cross-linked products were visualized by immunoblotting using (b) an anti-TatB peptide antibody or (c) an anti-TatC
antibody. The asterisks indicate likely TatBC cross-links. (d ) Structural model of TatB interacting with TatC at the polar cluster site (adapted from [15]). The backbone
distances between TatBL9/TatCM205 and TatBG16/TatCV198 are shown. (e) Whole cells of strain MC4100DBC producing TatBL9C alongside TatCF94A,E103,/M205C or TatCF94A/
E103A/F213C from plasmid p101C*BC (annotated TatCFEA,M205C or TatCFEA,F213C, respectively) were left untreated (C) or incubated for 1 min with 1.8 mM CuP (O) as
indicated. Following membrane preparation, cross-links were detected with an anti-TatB peptide antibody.
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First we confirmed that Tat activity was not abolished fol-
lowing introduction of any of these substitutions by showing
that each pair of Cys-substituted proteins was able to support
growth of DADE-P in the presence of 2% SDS (electronic sup-
plementary material, figure S1b,c). Subsequently we
undertook cross-linking analysis in vivo using the same pro-
tocol as that used for TatB–TatC cross-linking. Under the
conditions tested, no cross-links were detected between
TatA and the TatC polar cluster residue M205C (figure 3a;
electronic supplementary material, figure S3), indicating
that TatA is not present at this site. Instead, a band of the
expected size for a TatA–TatC heterodimer was detected
under oxidizing conditions in cells co-producing TatAL9C
and TatCF213C. This was confirmed as a cross-link between
TatC and TatA because it was also cross-reactive with an
anti-TatA antibody (figure 3b). A similar band was also
detectable under oxidizing conditions when TatAL9C and
TatCF213C were produced alongside wild-type TatB at much
lower levels from plasmid pTAT101 (figure 3c). Scanning
analysis using TatAL10C revealed a faint cross-link with
TatCV212C following oxidation (electronic supplementary
material, figure S3a), and TatAI11C gave detectable cross-
links with TatCV212C and TatCF213C (electronic supplementary
material, figure S3b).
Taken together, the absence of a TatA cross-link at the
TatC polar cluster site along with clear cross-links between
TatAL9C/L11C and the N-terminal end of TatC TM6 suggests
that TatA occupies a distinct binding site. Co-evolutionary
analysis identified a weak evolutionary coupling between
TatA/B residue 17 and TatC residue 227 (E. coli numbering),
that was much lower than the primary contacts identified
previously [15]. Guided by this and the TatA/TatC
cross-links identified above we were able to dock TatA into
a binding site that lies adjacent to the polar cluster site
(figure 3d and figure 4a). Atomistic molecular dynamic simu-
lations suggested that TatA was stable in this site (electronic
supplementary material, figures S4A, S5) and together with
the modelling predicted further contacts between TatA and
TatC including S5–F213, I6–V212 and A13–I220. To confirm
this, we constructed cysteine substitutions at each of these
predicted pairs, and were able to detect oxidant-induced
TatA–TatC heterodimers at each of these positions
(figure 3e–g). We were also able to detect a very faint hetero-
dimeric cross-link between TatAV17C and TatCE227C
(figure 3h). We conclude that TatA occupies a binding site
that is distinct from, but adjacent to, the polar cluster site.
TatA associates with TatC in two different modes. One of
these is constitutive, whereas the second is induced in the
presence of substrate and is associated with Tat transport
[15–17,20,24]. Substrate-induced assembly of TatA can be
abolished by alanine substitution of two key residues of
TatC, F94 and E103, which constitute the signal peptide bind-
ing site [21]. To determine whether TatA interaction at this
newly identified site was independent of substrate-binding
we introduced the F94A and E103A substitutions into
TatCF213C and probed for interaction with TatAL9C.
Figure 3i shows that the TatAC cross-link was still strongly
detected, and therefore arises due to substrate-independent
binding of TatA.
Collectively these results demonstrate that there are two
binding sites for TatA family proteins on E. coli TatC and
that under resting conditions TatB occupies the TM5/polar
cluster site while TatA is bound at the TM6 site. Molecular
modelling suggests that both of these sites can be simul-
taneously occupied on a single TatC (figure 4a). Atomistic
molecular dynamics suggest that this ternary complex is
stable as a TatA1B1C1 heterotrimer (electronic supplementary
material, figure S4a, S5), with stability further increased for a
TatA3B3C3 oligomer (electronic supplementary material,
figure S4b, S6), and structural stability plots indicate that
the secondary structure in the starting models was preserved
(electronic supplementary material, figure S7a,c).
2.3. TatA and TatB are each capable of occupying both
binding sites
Having defined two binding sites on TatC for a TatA/B TM
helix, and identified diagnostic cysteine cross-linking pos-
itions for each site, we next asked the question whether
TatA and TatB were each capable of occupying both binding
sites if they were the only TatA family protein present.
Figure 5a shows that in the absence of TatB, a Cys substi-
tution at TatAL9 still disulfide cross-links with TatCF213C,
indicating that it occupies the TM6 binding site. However,
additional cross-links were now also detected between
TatAL9C and TatCM205C/L206C which are adjacent to the
polar cluster site. This finding indicates that TatA is capable
of binding in both sites.
When TatA was absent, cross-links of TatBL9C to
TatCM205C and TatCL206C were still detected, indicating occu-
pancy at the polar cluster site, but additional cross-links were
also now detected between TatBL9C and TatCS214C/Q215C,
showing that TatB can also bind at the TM6 binding site if
this site is vacant (figure 5b). Thus we conclude that each
protein is able to occupy both binding sites.
2.4. TatA and TatB switch binding sites in the presence
of a Tat substrate
We next addressed whether differential occupancy of TatA
and TatB at these binding sites was functionally related to
Tat transport. To this end we undertook disulfide cross-link-
ing analysis in the presence of an overproduced Tat substrate,
CueO. We focused initially on the interaction of TatBL9C and
TatCM205C that reports on the presence of TatB at the polar
cluster site. When CueO was overproduced, the level of
cross-linking between TatBL9C and TatCM205C appeared to
diminish and the level of TatB and TatC homodimers to
increase compared to those seen in the presence of endogen-
ous substrate proteins (figure 6a). It should be noted, in
agreement with this, that substrate-induced TatC homodi-
merization through M205C has previously been observed
[11]. This finding is consistent with the idea that there is
substrate-induced movement of TatBL9 away from TatCM205.
To determine whether TatB may now occupy the second
TatA/TatB binding site, we probed for cross-links between
TatBL6C, TatBL9C, TatBL10C or TatBL11C and Cys substitutions
at positions 213, 216 or 217 of TatC, each in the presence of
overproduced CueO. Figure 6b shows that a cross-link
could be detected between TatBL9C and TatCF213C.
Substrate-induced reduction in cross-linking between
TatBL9C and TatCM205C and a concomitant increase in the
TatBL9C and TatCF213C cross-link is also shown for a different
plasmid construct in the electronic supplementary material,
figure S8a.
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It was noted in figure 2 that in the presence of endogen-
ous substrate a very faint cross-link between TatBL9C and
TatCF213C could be detected with the anti-TatB antibody
(but not the anti-TatC antibody), and this can also be seen
in the electronic supplementary material, figure S8A. The
observation that this cross-link was abolished when substrate
binding to the TatBC complex was prevented by introduction
of the TatCF94A,E103A substitutions (figure 2f ), even when sub-
strate was overproduced (figure 6c), strongly suggests that
docking of a substrate to the receptor complex triggers the
movement of TatB into the TM6 binding site.
As TatB can occupy the TM6 site in the presence of over-
produced substrate, it should be accompanied by loss of TatA
from this binding site. Figure 6d shows, in agreement with
this, that a cross-link between TatAL9C and TatCF213C could
no longer be detected when CueO was overproduced. A
further repeat of this experiment shown in the electronic sup-
plementary material, figure S8a confirms the reduction in
TatAL9C–TatCF213C cross-linking when CueO was
overproduced. Thus, overproducing a Tat substrate results
in a change of occupancy at the TM6 binding site, with
TatB replacing TatA. To determine whether TatA was now
present at the polar cluster binding site, cross-linking
between TatAL9C and TatCM205C was analysed in the pres-
ence of CueO. Figure 6d indicates that overproduced
substrate induced the formation of a cross-link between
these residues in TatA and TatC and that therefore TatA is
able to occupy the polar cluster site in the presence of sub-
strate. An increase in the level of the TatAL9C–TatCM205C
heterodimeric cross-link with increasing substrate production
is also shown in the electronic supplementary material, figure
S8b,c. It should be noted, however, that at the same level of
exposure as the other TatAC and TatBC cross-linking ana-
lyses, the TatAL9C–TatCM205C heterodimer was too weak to
be detected (electronic supplementary material, figure S8a).
The reason for this is not clear but it is possible that the occu-
pancy and/or conformation of TatA at the polar cluster might
be influenced by the further polymerization of TatA
25
37
kDa
50
25
37
TatC
TatC2
TatAC
kDa
TM5 P3 TM6 TM5 P3 TM6
oxidizing: a-TatC reducing: a-TatC
TatAL9C + TatC
(a)
TatC
TatAC
TatC2
AL9C
CV212C
AL9C
CF213C
O R O R
(c)
25
37
kDa
a-TatA a- TatC
a-TatC a-TatC a-TatC a-TatC a-TatC
O R
TatAC
TatA2
AL9C
CF213C
(b)
(e)
50
37
25
kDa
TatC
TatC2
TatAC
AI6C
CV212C
50
37
25
kDa
TatC
TatC2
TatAC
AS5C
CF213C
( f ) (g)
TatC2
TatAC
TatC
kDa
50
37
25
AA13C
CI220C
TatC2
TatAC
TatC
50
25
37
kDa
AL9C
CFEA,M205C
AL9C
CFEA,F213C
(i)
TatC2
TatAC
TatC
AV17C
CE227C
50
37
25
kDa
O R O R O R C O C O
O R
(h)
*
(d)
M
20
5C
L2
06
C
L2
07
C
T2
08
C
P2
09
C
P2
10
C
D2
11
C
V2
12
C
F2
13
C
S2
14
C
Q2
15C
T2
16
C
M
20
5C
L2
06
C
L2
07
C
T2
08
C
P2
09
C
P2
10
C
D2
11
C
V2
12
C
F2
13
C
S2
14
C
Q2
15C
T2
16
C
TatAC
S5F213
I220
E227
L9
I6
A13
V17
11 Å
6.1 Å
7.9 Å
5.5Å
Figure 3. TatAL9C interacts with TatCF213C in vivo. (a,e,g,h) Western blot analysis (separated on 12.5% polyacrylamide gels) of whole cells of E. coli strain DADE-P
producing the indicated Cys substitutions in TatA and TatC (and wild-type TatB, from plasmid pUNITATCC4) following exposure to 1.8 mM CuP (oxidizing) or 10 mM
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(b) The TatAL9C–TatCF213C oxidized (O) and reduced (R) samples from (a) were separately probed with an anti-TatA antibody (note that the TatA monomer that is in
large excess has been run off the bottom of the gel). (c,f ) Cells of strain DADE harbouring plasmid pTAT101 producing (c) TatAL9C and wild-type TatB along with
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Structural model of TatA interacting with TatC at the TatA constitutive binding site. The backbone distances between TatAS5/L9/TatCF213, TatAI6/TatCV212,
TatAA13/TatCI220 and TatAV17/TatCE227 are shown. (i) Cells of strain DADE producing TatAL9C and wild-type TatB alongside TatCF94A,E103A,M205C or TatCF94A,E103A,F213C (anno-
tated TatCFEA,M205C or TatCFEA,F213C, respectively) from pTAT101 were left untreated (C) or incubated with 1.8 mM CuP (O) for 1 min. For (c,d), following quenching,
membranes were prepared, samples separated by SDS-PAGE (12.5% polyacrylamide) and immunoblotted using an anti-TatC antibody.
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molecules during the assembly of the transport-associated
TatA oligomer.
Molecular dynamic simulations have previously shown
that TatA can stably interact with TatC through the polar
cluster site [15]. A similar analysis indicates that TatB can
bind at the TatA constitutive site and that it can stably
occupy that site when TatA is bound at the polar cluster site
(electronic supplementary material, figures S9, S10). A model
for the substrate-activated state of the TatABC complex is
shown in figure 4b.
3. Discussion
In this study, we have used disulfide cross-linking to probe
the interaction of TatA and TatB with TatC under resting con-
ditions and in the presence of an over-expressed substrate.
Our results have delineated two binding sites for these
proteins. One of these—the ‘polar cluster’ site—has been
identified previously and involves key interactions between
a polar side chain at position 8 of TatA/B and a patch of con-
served residues, M205, T208 and Q215, in TatC [15]. The
second site lies adjacent to the polar cluster site, at TM6 of
TatC. Experiments where TatA or TatB were present indivi-
dually as the sole TatA/B family protein indicated that each
of these proteins was capable of occupying both sites. How-
ever, locking the Tat system into the resting state through the
introduction of substitutions in TatC that prevent signal
peptide binding demonstrated that TatB occupies the polar
cluster site under these circumstances, as proposed previously
[15], with TatA occupying the newly identified site. Modelling
and MDS suggested that interaction of TatA with the TM6
binding site was stable and that both of these sites can be sim-
ultaneously occupied on one TatC protein. This adjacent
positioning of TatA and TatB is supported by the detection
of TatA–TatB cross-links when a photocrosslinker is intro-
duced into the N-terminal region of TatB [20].
Recently, a molecular model of the multivalent resting-
state TatBC complex was built by docking TatBC protomers
together using evolutionary couplings between TatC proteins
and cross-links between the TatC TM1 and the TatB TM helix
[15,20]. Updated models for the resting TatABC complex con-
taining either three or four copies of the heterotrimer can be
seen in figure 7. TatA can be readily accommodated into the
complex with minimal adjustment, slotting into a groove that
is present at the outside of the complex. This peripheral bind-
ing of TatA probably explains why a TatBC complex can be
stably purified when TatA is absent (e.g. [36,37]) and may
potentially account for findings that TatA is variably shed
from the TatBC complex during purification in detergent
solution [10,38].
When a Tat substrate protein is overproduced, we show
that the level of TatA cross-linking at the TM6 site is reduced
and that TatA becomes detectable by cross-linking at the
polar cluster site. This is accompanied by a reduction in
the level of TatB cross-linking at the polar cluster site and
the appearance of TatB–TatC cross-links at the TatA constitu-
tive site. In agreement with this, substrate-dependent contacts
between the chloroplast TatA orthologue Tha4 and cpTatC at
the equivalent polar cluster site have also been observed [16].
Position-switching of TatA and TatB is probably triggered by
signal peptide binding at the complex. In the deep-binding
mode, contacts have been detected between the signal pep-
tide h-region and both the TatB TM helix and TatC TM5,
end-on view
end-on view
TatA TatB
TatC
periplasmic view
1
2
345 6
side-on view
TatATatB
TatC
periplasmic view
1
2
345 6
side-on view
(a)
(b)
Figure 4. Models of the TatABC trimer in the resting and activated state. Three views of (a) the resting-state TatABC complex and (b) the substrate-activated TatABC
complex. TatA is shown in silver, TatB gold and TatC green. Note that in (b) the substrate signal peptide is not shown as it is currently unclear precisely where it
binds in the activated state.
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close to the polar cluster site [16,19,20]. While current find-
ings cannot distinguish whether it is TatA or TatB that
makes the initial movement, based on previous findings we
speculate it is TatB. It has been shown by several genetic
studies that suppressors of inactive twin-arginine signal pep-
tides or a defective TatC signal peptide binding site locate
primarily to the TM helix of TatB. No such suppressors
have yet been identified in TatA. Cross-linking analysis indi-
cated that at least some of these TatB suppressor variants
caused rearrangement at the polar cluster site, probably by
decreasing TatB binding affinity at this site and/or increasing
binding affinity for the constitutive site [39–41]. It has been
shown that Tat signal peptides are sequestered within a
cavity comprising TatB and TatC, which could potentially
correspond to the central cavity seen in the modelled
TatBC/TatABC complexes (figure 4b and [15,20]). Note that
the polar cluster site is adjacent to the lumen of this cavity
and, accordingly, docking of the signal peptide close to this
region may cause conformational rearrangements that drive
TatB from the polar cluster site into the TatA constitutive site.
In addition to changes in TatA and TatB cross-linking
patterns, we note that signal peptide binding also resulted
in the formation of TatB homodimers through L9C, and
TatC homodimers mediated through TatC M205C or
through F213C. The formation of a substrate-induced TatC
M205C homodimer has been observed previously and
taken to report on the activated state of the Tat translocase
[11,39]. The head-to-tail arrangement of TatC in the rest-
ing-state model of TatABC complex positions
neighbouring TatC M205 residues 25 A˚ away from each
other, and F213 residues even further apart, a distance
that is too great for disulfide bond formation through Cys
sidechains at these positions. This strongly suggests that
there must be a significant conformational change in the
TatABC complex upon substrate binding to bring TatC pro-
tomers into a tail-to-tail organization. Opening up of the
complex in this way would then allow TatA to access the
vacated polar cluster site. It should be noted that the con-
cave face of TatC has been implicated in the nucleation of
the transport-active TatA oligomer [9,16]. Binding of a
TatA molecule at the polar cluster site places it adjacent to
the concave face where it could potentially initiate polymer-
ization of further TatA molecules.
In conclusion, we have defined two binding sites for TatA
family proteins within the TatABC complex and have demon-
strated differential occupancy of TatA and TatB at these sites
during different stages of Tat transport. These findings help
to explain a long-standing observation that overproduction
of TatB relative to TatA and TatC inactivates the Tat system
[7], because simultaneous occupancy of TatB (which is
normally present 20-fold less than TatA [31,42]) in both
binding sites would be expected to block progression through
the transport cycle.
4. Material and methods
4.1. Strains and plasmids and growth conditions
All strains used for cross-linking analysis are derived from
MC4100 (F2, [araD139]B/r, D(argF-lac)U169, l
2, e14-,
flhD5301, D( fruK-yeiR)725( fruA25), relA1, rpsL150(StrR),
rbsR22, D( fimB-fimE)632(::IS1), deoC1—[43]). MC4100DBC
(as MC4100, DtatBC—[21]), DADE (as MC4100, DtatABCD
DtatE—[44]) and DADE-P (as DADE, pcnB1 zad-981::Tn10d
(Kanr)—[34]) were used where indicated in the figure
legends. Strain JM109 (F0 traD36 proAþBþ lacIq D(lacZ)M15/
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Figure 5. TatA and TatB can each occupy both binding sites on TatC. (a) Western blot analysis (separated on 12.5% polyacrylamide gels) of whole cells of E. coli
strain DADE-P producing TatAL9C alongside the indicated Cys substitutions in TatC (in the absence of TatB, from plasmid pUNITATCC4DB) following exposure to
1.8 mM CuP (oxidizing) or 10 mM DTT (reducing) for 1 min. Cross-linked products were visualized by immunoblotting using anti-TatC antibodies. (b) Western
blot analysis (separated on 10% polyacrylamide gels) of membranes from E. coli strain DADE producing TatBL9C alongside the indicated Cys substitutions
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D(lac-proABI glnV44 e142 gyrA96 recA1 relA1 endA1 thi
hsdR17) was used for cloning purposes.
All plasmids used in this study are listed in the electronic
supplementary material, table S1. Plasmid pUNITATCC4
encodes TatA, TatB and cysteine-less TatC in plasmid
pQE60. Production of the encoded proteins is driven by the
phage T5 promoter which is constitutively active in strains
deleted for lacI, such as MC4100 derivatives. Plasmid pUNI-
TATCC4DB (producing TatA and TatC) was derived from
pQEA(DB)C [45] by excising DNA covering the wild-type
allele of tatC through digestion with XhoI and BamHI and
replacement with a Cys-less tatC allele amplified using
oligonucleotides TatBdeldownXho [45] and TatCBam [34]
with pUNITATCC4 as template. Plasmid pTAT101 codes
for TatA, TatB and TatC on a low copy number vector and
produces these proteins at approximately four times chromo-
somal level [32]. Plasmid p101C*BC expresses tatBC at
approximately chromosomal level and has been described
previously [21]. p101C*BC Cys-less was designed as follows:
a tatBC allele where all of four Cys codons of tatC had been
mutated to Ala codons was amplified from pTat101 Cys-
less [11] using primers BamHI-TatB-F and SpHI-TatC-R (elec-
tronic supplementary material, table S2), introducing a SphI
site at the 30-end of tatC. The PCR product was digested
with BamHI/SphI and cloned into similarly digested
p101C*BC. All point mutations in plasmids were introduced
by Quickchange site-directed mutagenesis (Stratagene) using
the primers listed in the electronic supplementary material,
table S2. Plasmid pQE80-CueO expresses E. coli CueO with
a C-terminal his6 tag and has been described previously
[46]. Plasmid pTGS encodes GFP fused to the TorA signal
sequence and a C-terminal SsrA tag [47].
Phenotypic growth in the presence of 2% SDS was
assessed by culturing strains of interest in LB medium con-
taining appropriate antibiotics until an OD600 of 1 was
reached, after which 5 ml aliquots of culture were spotted
onto agar plates containing LB or LB supplemented with
2% SDS and appropriate antibiotics. Plates were incubated
at 378C for 16 h after which they were photographed.
Antibiotics were used at the following concentrations: chlor-
amphenicol (25 mg ml21), kanamycin (50 mg ml21) and
ampicillin (125 mg ml21).
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Figure 6. TatA and TatB cross-linking patterns are altered in the presence of an overproduced Tat substrate. (a) Strain MC4100DBC harbouring plasmid
p101C*BC producing TatBL9C alongside TatCM205C and plasmid pQE80-CueO where indicated, were left untreated (control, C), or incubated with 1.8 mM CuP
for 1 min (O). Membrane fractions were prepared, separated by SDS-PAGE (10% polyacrylamide) and immunoblotted with anti-TatBFL, anti-TatC as indicated.
An aliquot of the soluble fraction following membrane preparation was retained and analysed by immunoblotting with an anti-Histag antibody. (b) Strain
MC4100DBC producing the indicated Cys variants of TatB and TatC from plasmid p101C*BC and his-tagged CueO from pQE80-CueO were incubated with
1.8 mM CuP for 1 min. Following quenching, membrane fractions were separated by SDS-PAGE (10% polyacrylamide) and immunoblotted with an anti-
TatC antibody. A non-oxidized sample of membranes harbouring TatBL9C– TatCMF213C is shown in the left-most lane. An aliquot of the soluble fraction
from each sample was retained and analysed by immunoblotting with an anti-Histag antibody. (c) Whole cells of strain MC4100DBC producing TatBL9C alongside
TatCF213C or TatCF94A,E103A,M205C (annotated TatCFEA,M205C) from plasmid p101C*BC, and his-tagged CueO ( from pQE80-CueO) were incubated for 1 min with
1.8 mM CuP. Following membrane preparation, cross-links were detected with an anti-TatB peptide antibody or an anti-TatC antibody. An aliquot of the soluble
fraction from each sample was retained and analysed by immunoblotting with an anti-Histag antibody. (d ) Strain DADE harbouring plasmid pTAT101 producing
wild-type TatB, TatAL9C and either TatCM205C or TatCF213C along with plasmid pQE80-CueO were left untreated (control, C), or incubated with 1.8 mM CuP for
1 min (O). Membrane fractions were separated by SDS-PAGE (12.5% polyacrylamide) and immunoblotted with an anti-TatC antibody. An aliquot of the soluble
fraction from each sample was retained and analysed by immunoblotting with an anti-Histag antibody. p: precursor, m: mature forms of substrate CueO-His *
indicates an oxidation product of CueO.
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4.2. In vivo disulfide cross-linking experiments
For Tat proteins produced at close to native level (from
pTAT101 and p101C*BC), the appropriate E. coli strain/plasmid
combination was cultured overnight in LB medium contain-
ing appropriate antibiotics. Cells were diluted 1 : 100 into
fresh LB medium supplemented with appropriate antibiotics
and cultured aerobically until an OD600 of 0.3 was reached.
For the CuP titration experiment, six 25 ml aliquots were
withdrawn and each supplemented with fresh LB medium
to a final OD600 of 0.15. The first aliquot was left untreated
(control), the second one was supplemented with 10 mM
DTT (reducing) and the remainder were incubated with
0.3, 0.6, 1.2 or 1.8 mM CuP (oxidizing). Cells were incubated
for 15 min at 378C with agitation, then harvested, resus-
pended in 1 ml 20 mM Tris–HCl, pH 7.5, 200 mM NaCl,
12 mM EDTA, 8 mM N-ethylmaleimide and incubated at
378C for 10 min to quench free sulfhydryls. The cell suspen-
sion was supplemented with protease inhibitor cocktail
(Roche) and disrupted by sonication. Unbroken cells were
removed by centrifugation (10 000g for 5 min at 48C) and
the supernatant ultracentrifuged (200 000g for 30 min at
48C). The membrane pellet was resuspended in 70 ml 1
Laemmli buffer lacking b-mercaptoethanol (BioRad). For
the time course experiment, when subcultured cells reached
OD600 of 0.3, seven 25 ml aliquots were withdrawn and sup-
plemented with fresh LB medium to a final OD600 of 0.15.
One aliquot was left untreated, one was supplemented
with 10 mM DTT and the remainder incubated with
1.8 mM CuP for 1, 2, 5, 10 or 15 min at 378C with agitation.
The reactions were quenched for 10 min as before and a
small aliquot of cells from each sample was withdrawn, seri-
ally diluted and spread on LB plates supplemented with
appropriate antibiotics to assess viability. Membrane
samples were prepared from the remainder of the cells and
treated as described above. For all other experiments, when
cells reached OD600 0.3, three separate 25 ml aliquots were
withdrawn and supplemented with fresh medium to OD600
of 0.15. One aliquot was left untreated, the second sup-
plemented with 10 mM DTT and the third incubated with
1.8 mM CuP for 1 min at 378C with agitation. The reactions
were quenched and membrane samples prepared as
described before. When experiments were performed in the
presence of overproduced CueO, cells additionally
harboured pQE80-CueO and IPTG was included in the
initial subculture. IPTG was added to a final concentration
of 1 mM unless otherwise stated.
For Tat proteins produced at higher copy from plasmid
pUNITATCC4, overnight cultures of DADE-P harbouring
pUNITATCC4 were subcultured at 1 : 100 to inoculate fresh
LB containing appropriate antibiotics. When cells reached
OD600 of 0.3, three 2.5 ml aliquots were withdrawn and
made up to 5 ml with fresh LB to a final OD600 of 0.15.
These aliquots were treated and quenched as described
above after which the cells were harvested at 16 000g for
1 min and resuspended in 40 ml of 1 Laemmli buffer lacking
b-mercaptoethanol (BioRad). Where experiments were under-
taken in the presence of TorAss-GFP-SsrA, cells were
subcultured until an OD600 of 0.25 was reached, after which
L-arabinose at concentrations between 0.001 and 0.01% was
added and cells incubated aerobically for a further 20 min
before being diluted to a final OD600 of 0.15 and treated as
described above. Although high concentrations of L-arabinose
are toxic to E. coli MC4100 strain derivatives, control growth
experiments confirmed that at the concentrations used here
there was no loss of cell viability.
For analysis, sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE) was performed using Tris-gly-
cine gels [48]. In total, 20 ml of sample was analysed in each
case. Following electrophoresis, proteins were transferred to
nitrocellulose membrane (I-blotw system, Life Technologies).
TatA and TatC were identified using the polyclonal
antibodies previously described [11,31]. Two different TatB
antisera were used. One of these was raised against
full-length TatB [31] and in this study is annotated as
TatBFL. The second was raised against two peptides of
E. coli TatB 69–84 and TatB 156–171, and was then affinity
purified with peptide 156–171 [15] and in this study is
referred to as a TatB peptide antibody. Abcam Anti-6X His
tagw antibody [GT359] (HRP conjugate) was purchased (cat-
alogue number ab184607), and an HRP-conjugated goat anti-
rabbit antibody (BioRad, catalogue number 170–6515) was
used as secondary antibody for the TatA, TatB and TatC anti-
sera. Cross-reacting bands were visualized after incubation
cytoplasmic viewside viewperiplasmic view(a)
(b)
Figure 7. Models of the multimeric resting-state TatABC complex. Models based on (a) three or (b) four heterotrimers. Modified from Alcock et al. [15].
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with ClarityTM Western ECL Blotting Substrate (BioRad)
using a CCCD camera (GeneGnome XRQ, Syngene).
4.3. Molecular modelling and simulations
Molecular modelling was carried out as described previously
[15]. All images were generated using PYMOL (The PyMol
Molecular Graphics System, Version 1.8, Schro¨dinger, LLC).
Multimers were built using TatA–TatC/TatB–TatC disulfide
cross-links as unambiguous constraints for docking using
HADDOCK [49]. In all of these experiments, TatA is mod-
elled from residues G2 to G21, TatB from residues F2 to
G21 and TatC from residues T11 to F235.
All MDS were performed using GROMACS v. 5.1.2 [50].
The Martini 2.2 force field [51] was used to run initial 1 ms
coarse-grained (CG) MDS to permit the assembly and
equilibration of 1-palmitoyl, 2-oleoyl phosphatidylglycerol :
1-palmitoyl, 2-oleoyl phosphatidylethanolamine bilayers
around the TatABC complexes at a 1 : 3 molar ratio [52].
CG molecular systems were converted to atomistic detail
using CG2AT [53], with Alchembed used to remove any
unfavourable steric contacts between protein and lipid [54].
The heterotrimeric atomistic systems equate to a total size
of approximately 80 000 atoms and box dimensions in the
region of 125  125  100 A˚3, while the heterononameric sys-
tems comprised approximately 115 000 atoms, with box
dimensions in the region of 100  100  100 A˚3. The systems
were equilibrated for 1 ns with the protein restrained before
three repeats of 100 ns of unrestrained atomistic MDS, for
each configuration of the molecular system (see below),
using the Gromos53a6 force field [55]. Molecular systems
were neutralized with a 150 mM concentration of NaCl.
All simulations were executed at 378C, with protein,
lipids and solvent separately coupled to an external bath,
using the velocity-rescale thermostat [56]. Pressure was main-
tained at 1 bar, with a semi-isotropic compressibility of 4 
1025 using the Parrinello–Rahman barostat [57]. All bonds
were constrained with the LINCS algorithm [58]. Electro-
statics was measured using the Particle Mesh Ewald
method [59], while a cut-off was used for Lennard–Jones
parameters, with a Verlet cut-off scheme to permit GPU
calculation of non-bonded contacts. Simulations were per-
formed with an integration time step of 2 fs. Analysis was
performed using GROMACS tools and locally written
python and perl scripts.
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